Skip to content

Pyridoxine Dependent Epilepsy Caused By Aldh7a1 Mutant Cn293409

Published: July 22, 2026Updated: August 25, 2026

A genetic epilepsy disorder requiring pyridoxine (vitamin B6) supplementation to control seizures. Symptoms often appear shortly after birth and untreated cases can lead to developmental delay.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Refractory seizures

!

Metabolic acidosis

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(neurological)

Sensorineural hearing loss

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Pyridoxine (Vitamin B6) Supplementation

Lifelong pyridoxine supplementation is the cornerstone of treatment for pyridoxine-dependent epilepsy caused by ALDH7A1 mutations. High-dose supplementation can prevent seizures and improve neurodevelopmental outcomes when initiated early.

medication
3

Lysine Restriction with Arginine Supplementation

Reducing dietary lysine decreases the accumulation of pipecolic acid and alpha-aminoadipic semialdehyde, toxic metabolites in this condition. Combined with arginine supplementation, this approach complements pyridoxine therapy.

dietary

Additional treatment options

Ketogenic Diet

The ketogenic diet may provide additional seizure control in pyridoxine-dependent epilepsy. This high-fat, low-carbohydrate diet can help reduce seizure frequency in treatment-resistant cases.

dietary

Anti-Epileptic Drug Adjunct Therapy

Some patients may require anti-epileptic medications as adjuncts to pyridoxine therapy. Seizure control may be achieved with lower AED doses when combined with pyridoxine.

medication

Metabolic and Neurological Monitoring

Regular monitoring of pipecolic acid levels, EEG studies, and neurodevelopmental assessments are essential. Urine alpha-aminoadipic semialdehyde monitoring helps assess treatment efficacy.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pyridoxine Dependent Epilepsy Caused By Aldh7a1 Mutant Cn293409?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Baxter P, Stockler S, Yaplito-Lee J. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy. Neurology. 2022.

guideline2022
2

van Karnebeek CD, Hartmann H, Jaggumantri S. Pyridoxine-dependent epilepsy caused by ALDH7A1 deficiency: long-term outcomes of aggressive treatment. J Pediatr. 2021.

clinical_trial2021
3

Mills PB, Struys E, Jakobs C. Pyridoxine-dependent epilepsy caused by mutations in ALDH7A1: the emerging role of lysine degradation. Mol Genet Metab. 2020.

review2020
4

Coughlin CR, Gospe SM Jr, Mercimek-Mahmutoglu S. Epilepsy in pyridoxine-dependent epilepsy: a systematic review of the literature. Epilepsia. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Pyridoxine Dependent Epilepsy Caused By Aldh7a1 Mutant Cn293409. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy